Cargando…
Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo
High-grade serous carcinoma (HGSC) is the most common and aggressive subtype of epithelial ovarian cancer, characterized by gain-of-function TP53 mutations originating in the fallopian tube epithelium. Therapeutic intervention occurs at advanced metastatic disease, due to challenges in early-stage d...
Autores principales: | Pereira, Madison, Glogova, Alice, Haagsma, Jacob, Stewart, Julia, Shepherd, Trevor G., Petrik, Jim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662458/ https://www.ncbi.nlm.nih.gov/pubmed/37986175 http://dx.doi.org/10.1186/s13048-023-01307-x |
Ejemplares similares
-
Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy
por: Pereira, Madison, et al.
Publicado: (2022) -
Gain-of-function p53(R175H) blocks apoptosis in a precursor model of ovarian high-grade serous carcinoma
por: Haagsma, Jacob, et al.
Publicado: (2023) -
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
por: Cook, David P., et al.
Publicado: (2023) -
Principles of dormancy evident in high-grade serous ovarian cancer
por: Shepherd, Trevor G., et al.
Publicado: (2022) -
A dog oviduct-on-a-chip model of serous tubal intraepithelial carcinoma
por: de Almeida Monteiro Melo Ferraz, Marcia, et al.
Publicado: (2020)